Literature DB >> 15652752

Stat5 tetramer formation is associated with leukemogenesis.

Richard Moriggl1, Veronika Sexl, Lukas Kenner, Christopher Duntsch, Katharina Stangl, Sebastien Gingras, Angelika Hoffmeyer, Anton Bauer, Roland Piekorz, Demin Wang, Kevin D Bunting, Erwin F Wagner, Karoline Sonneck, Peter Valent, James N Ihle, Hartmut Beug.   

Abstract

Activation of Stat5 is frequently found in leukemias. To study the mechanism and role of Stat5 activation, we introduced a constitutively activated Stat5a mutant, cS5F, into murine bone marrow (BM) cells. BM transplantation with cS5F-transfected cells caused development of multilineage leukemias in lethally irradiated wild-type or nonirradiated Rag2(-/-) mice. The leukemic cells showed strongly enhanced levels of cS5F tetramers but unchanged cS5F dimer levels in a DNA binding assay. Moreover, Stat5a mutants engineered to form only dimers, but not tetramers, failed to induce leukemias. In addition, Stat5 tetramers were found to accumulate in excess compared to dimers in various human leukemias. These data suggest that Stat5 tetramers are associated with leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652752     DOI: 10.1016/j.ccr.2004.12.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  105 in total

1.  Turning transcription on or off with STAT5: when more is less.

Authors:  Michael A Farrar; Lynn M Heltemes Harris
Journal:  Nat Immunol       Date:  2011-11-16       Impact factor: 25.606

Review 2.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

3.  Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.

Authors:  Katrin Friedbichler; Marc A Kerenyi; Boris Kovacic; Geqiang Li; Andrea Hoelbl; Saliha Yahiaoui; Veronika Sexl; Ernst W Müllner; Sabine Fajmann; Sabine Cerny-Reiterer; Peter Valent; Hartmut Beug; Fabrice Gouilleux; Kevin D Bunting; Richard Moriggl
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

Review 4.  [Tumor stem cell research - basis and challenge for diagnosis and therapy].

Authors:  Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2010-07-22       Impact factor: 1.704

Review 5.  JAK/STAT pathway dysregulation in tumors: a Drosophila perspective.

Authors:  Marc Amoyel; Abigail M Anderson; Erika A Bach
Journal:  Semin Cell Dev Biol       Date:  2014-03-28       Impact factor: 7.727

6.  The transcription factors signal transducer and activator of transcription 5A (STAT5A) and STAT5B negatively regulate cell proliferation through the activation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) and Cdkn1a expression.

Authors:  Ji Hoon Yu; Bing-Mei Zhu; Mark Wickre; Gregory Riedlinger; Weiping Chen; Atsushi Hosui; Gertraud W Robinson; Lothar Hennighausen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

Review 7.  The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition.

Authors:  Sylvane Desrivières; Christian Kunz; Itamar Barash; Vida Vafaizadeh; Corina Borghouts; Bernd Groner
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

8.  Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression.

Authors:  David Engblom; Jan-Wilhelm Kornfeld; Lukas Schwake; Francois Tronche; Andreas Reimann; Hartmut Beug; Lothar Hennighausen; Richard Moriggl; Günther Schütz
Journal:  Genes Dev       Date:  2007-05-15       Impact factor: 11.361

9.  Quantitative specificity of STAT1 and several variants.

Authors:  Basab Roy; Zheng Zuo; Gary D Stormo
Journal:  Nucleic Acids Res       Date:  2017-08-21       Impact factor: 16.971

10.  STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease.

Authors:  Geqiang Li; Kristy L Miskimen; Zhengqi Wang; Xiu Yan Xie; Jennifer Brenzovich; John J Ryan; William Tse; Richard Moriggl; Kevin D Bunting
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.